Skip to main content
Clinical Trials/ACTRN12616001714471
ACTRN12616001714471Completed未知

Effects of 12-week dairy-derived nutritional supplementation combined with physical activity on health and physical function on healthy middle aged women after a 2-week period of reduced activity

Anthony Blazevich0 sites100 target enrollmentStarted: December 14, 2016Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Prevention
Masking
Blinded (masking used)

Eligibility Criteria

Ages
40 Years to 60 Years (—)
Sex
Female

Inclusion Criteria

  • 1.age = 40-60 y
  • 3.BMI (18 -35 kg/m2)
  • 4.Sedentary to moderately active

Exclusion Criteria

  • 1.Previous negative reaction to milk or dairy proteins
  • 2.Previous negative reaction to fish
  • 3.Currently perform structured physical activity in their occupation
  • 4.Baseline protein above 1.2 g/kg/day
  • 5.Calcium intake of > 750 mg/day
  • 6.Alcohol > 14 drinks per week (average)
  • 7.Smoking (or only having stopped smoking within the last 2 years)
  • 8.T-score bone mineral density (BMD) at either the hip or lumbar spine < -2.5
  • 9.Have any fixations (i.e. spine or femoral rods, hip replacements)
  • 10.Irregular menstrual cycle (not within 20-35 days); lack of cycle is not a criterion
  • 11.Using hormone replacement therapy
  • 12.Planning to become pregnant or currently breastfeeding
  • 13.Using supplements such as vitamin D (>400 IU), calcium, bone/joint assistants (glucosamine, chondroitin), or antacids containing calcium carbonate, and not willing to stop for at least 6 weeks prior to, and throughout, the duration of the trial.
  • 14.Anti-inflammatory use (including aspirin, ibuprofen, omega 3)
  • 15. Rheumatoid arthritis
  • 16.Use of beta blockers or ACE inhibitors
  • 17.Metabolic bone disease (including osteoporosis, osteomalacia, osteogenesis imperfect and Paget’s disease)
  • 18.Endocrine disorders (including hyper- or hypo-thyroidism, parathyroid disease, diabetes mellitus and Cushing’s syndrome)
  • 19.Cancer (including cervical, ovarian, uterine, breast, liver and of the gastrointestinal system)
  • 20.Other medical conditions impacting on digestion, including diseases of the gastrointestinal tract, or previous operations such as gastrectomy or intestinal resection, or the liver (i.e. cirrhosis).
  • 21.Any chronic muscle disease, disorder or injury
  • 22.Asthma that is not controlled or other respiratory diseases
  • 23.Self-reported personal or family history of deep vein thrombosis or similar clotting disorders

Investigators

Sponsor
Anthony Blazevich

Similar Trials